Clinical Trials

NCT07000227 | RECRUITING | NA
60 participants

Mechanism of FODMAP Restriction on FGID Patients

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2025-07-20
Completion:
2026-06-30
Conditions
  • Functional Gastrointestinal Disorders (FGIDs)
  • Irritable Bowel Syndrome (IBS)
  • Functional Dyspepsia
Interventions
  • BEHAVIORAL
No Results Yet
NCT06997315 | RECRUITING | NA
30 participants

Bath Myorhythms Project

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2025-05-23
Completion:
2027-11-30
Conditions
  • Metabolic Regulation
Interventions
  • OTHER
No Results Yet
NCT06997068 | RECRUITING | PHASE2
25 participants

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2025-07-09
Completion:
2028-06-30
Conditions
  • Metastatic Oral Cavity Carcinoma
  • Recurrent Oral Cavity Carcinoma
  • Stage IVC Lip and Oral Cavity Cancer AJCC v8
  • Head and Neck Cancer
  • Hypopharynx Cancer
  • Oropharynx Cancer
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Metastatic Hypopharyngeal Carcinoma
  • Metastatic Laryngeal Carcinoma
  • Metastatic Malignant Head and Neck Neoplasm
  • Metastatic Oropharyngeal Carcinoma
  • Recurrent Hypopharyngeal Carcinoma
  • Recurrent Laryngeal Carcinoma
  • Recurrent Malignant Head and Neck Neoplasm
  • Recurrent Oropharyngeal Carcinoma
  • Stage IVC Hypopharyngeal Carcinoma AJCC v8
  • Stage IVC Laryngeal Cancer AJCC v8
  • Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Interventions
  • DRUG
  • PROCEDURE
  • OTHER
No Results Yet
NCT06992427 | RECRUITING | PHASE3
228 participants

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2025-06-05
Completion:
2029-08-15
Conditions
  • Head and Neck Squamous Cell Carcinoma
  • Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
  • Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
  • Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
  • Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Interventions
  • DRUG
  • RADIATION
  • PROCEDURE
  • OTHER
No Results Yet
NCT06951867 | RECRUITING
16640 participants

Tezspire Cardiac Events PASS

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-11
Start Date:
2025-09-15
Completion:
2029-05-31
Conditions
  • Cardiovascular Events
  • MACE
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page